Stockreport

Annovis Announces Unblinding of the Buntanetap Phase III Data in Parkinson's Disease [Yahoo! Finance]

Annovis Bio, Inc.  (ANVS) 
PDF developing novel therapies for neurodegenerative diseases, today announced successful completion of data cleaning for its Phase III study of buntanetap in patients with [Read more]